Focused Alpha’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$270K Buy
6,553
+281
+4% +$12.2K 0.07% 226
2026
Q2
$268K Buy
6,272
+783
+14% +$35K 0.07% 235
2026
Q1
$264K Buy
5,489
+1,198
+28% +$55.9K 0.08% 227
2025
Q4
$208K Buy
+4,291
New +$213K 0.06% 235

Other funds holding SNY

Focused Alpha's SNY Position: Q3 2026 in Review

Focused Alpha increased its Sanofi (SNY) stake by 4.5% in Q3 2026, buying an estimated $12.2K and bringing the position to 6,553 shares worth $270K. The position accounts for 0.07% of the portfolio, ranked #226.

Focused Alpha first reported a position in SNY in Q4 2025 and has held it in 4 quarters since. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Focused Alpha held 6,553 shares of Sanofi worth $270K as of Q3 2026.
  • Focused Alpha bought 281 Sanofi shares in Q3 2026, an estimated $12.2K.
  • Sanofi made up 0.07% of Focused Alpha's portfolio in Q3 2026, its #226 holding.
  • Focused Alpha first reported a position in Sanofi in Q4 2025 and has held it in 4 quarters since.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.